Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location:Home > Pharma China Web Edition > Editorials    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Editorials
 
MNCs Play Defensive despite China's Renewed Access and Trade Pled... 11/30/2017
Time for MNCs to Stay Sober as China Unleashes Enticing Drug Regu... 11/10/2017
China's Pharma Industry Agenda May Have Thorny Implications for M... 9/30/2017
Offshore Selling to the Chinese: Time to Take It More Seriously A... 8/31/2017
China Ups Role of Hospital Pharmacy Affairs as NRDL Negotiation C... 8/1/2017
Cost Containment Goes To A New Level with DRG Trial and Renewed C... 6/30/2017
Out of the Blue, CFDA Makes Giant Steps Forward to Boost Drug Inn... 6/5/2017
China Puts NRDL Negotiation, Medical Consortium and Hospital Refo... 5/1/2017
Is China Spring Finally Here for Innovative Drugs of MNCs? 3/31/2017
Another Shoe Yet to Drop despite Final Introduction of the 2017 N... 3/2/2017
Tough and Turbulent Time Ahead in the Coming Year of Trump Rooste... 2/2/2017
A New Storm Is Breeding for China Healthcare in the New Year 1/2/2017
Page:1/1  Total number of articles:12  [1]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links